V-85546

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameV-85546
Drug Alias NameV-85546AS-111793
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMatrix metalloproteinase 12 inhibitors
TargetsMatrix metalloproteinase 12
Therapy Area/IndicationsMultiple SclerosisPulmonary Disease, Chronic ObstructiveArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVernalis Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVernalis Plc
Active IndicationsN/A
Inactive IndicationsMultiple SclerosisPulmonary Disease, Chronic ObstructiveArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A